The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...
The US Food and Drug Administration said it is tracking multiple cases of H5N1 bird flu in domestic and wild cats, including ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Trump returns to the White House as the tenth wave of the COVID-19 pandemic once again inundates hospitals, while the last ...
Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine as concerns about a bird flu pandemic in humans ...
The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.
As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of new vaccines, including an mRNA shot.
HHS is investing more than $800 million in vaccine development and manufacturing capacity to strengthen the nation's response capabilities to emerging infectious disease threats, including bird flu.
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback